Navigation Links
Betting on Change - The Venture Forum in 2008
Date:5/14/2008

SANTA CLARA, Calif., May 14 /PRNewswire/ -- Shining a spotlight on the ever-growing field of life sciences, Larta Institute's 14th Annual Venture Forum will provide a ray of hope in the midst of the dark backdrop of the current economy. This year the Forum has the unparalleled opportunity to focus on brilliant entrepreneurs in the life sciences, even while concerns are surfacing on broader economic issues. "For 14 years, through good economic times and bad, the passion and ingenuity of entrepreneurs has been an inspiration for us all," says Rohit Shukla, CEO of Larta Institute. Therefore, Larta's focus on market-ready and well-coached seed-stage companies from across the globe attracts the most experienced, insightful and driven industry leaders to this "marketplace of ideas and solutions."

"Financing for innovation is always challenging, especially when the world economy is dealing with inflation, deflation, high energy prices, economic downturn and credit market crises," said G. Steven Burrill, CEO of Burrill & Company, and a featured keynote speaker. "The Venture Forum brings together innovation and capital in a creative atmosphere -- this kind of financing is the hallmark of an innovative society." Burrill & Company is co-producing the event with Larta Institute. The other noteworthy keynote speakers this year, including Boris Nikolic of the Gates Foundation and Mary Woolley, president of Research!America, and a host of seasoned industry executives, will describe and embrace the advancements, opportunities and pitfalls of this critical sector.

The Venture Forum is the culmination of Larta's close mentoring of showcased innovators over the course of many months, and as such is considered the premier platform for emerging companies to present and exhibit for serious investors and industry executives. "Larta's Venture Forum offers an exciting opportunity to view compelling emerging technology innovations -- this fits well with P&G Health Care's objectives, which are focused on external discovery to fill our pipeline," said Bruce Halpryn of Procter & Gamble Health Care. "The ideas being pitched at the Forum are of great interest to us in our continuing search for innovative technologies that could drive new business opportunities for P&G Health Care."

In this "rich brew of innovation," as Shukla refers to it, presenting companies are specially selected from the National Institutes of Health's Commercialization Assistance Program, managed by Larta institute. In addition, an equal number are selected from Larta's network, representing 36 states, 12 universities and entrepreneurs from Larta's Global Bridge network, this year featuring Brazil and Canada.

Larta Institute's track record of success ensures that this year's event will once again present great new business opportunities not seen on the regular conference circuit.

2008 Life Sciences Venture Forum, Friday, May 30 -- Santa Clara Convention Center: http://www.theventureforum.com

Attendee Registration: http://www.theventureforum.com/registration.asp

Credentialed Media: To register for press passes, contact Avi Kulokas at akulokas@larta.org or 213-538-1451.

Sponsorship Opportunities: For information on sponsorship, contact Carlos Gutierrez at cgutierrez@larta.org or 213-538-1453.

For information about Larta Institute, visit http://www.larta.org

Contact:

Constanza Pachon

Tel. 213/538-1451

Email: cpachon@larta.org

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE Larta Institute
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. AspenBio Pharma Shares to Trade on the NASDAQ Capital Markets Exchange Under Symbol APPY
2. American Stock Exchange Lists The Common Stock Of Neuralstem, Inc.
3. PDL BioPharma Announces Significant Strategic and Portfolio Changes to Focus on Antibody Discovery and Development
4. 3 strikes, youre out? Refiling of Amendment to Change Constitution to Criminalize Stem Cell Cures Shows Trouble with Anti-Cures Cause
5. Atrium Innovations Announces Management Changes
6. Genmab Announces Asset Exchange Agreement
7. Biomira announces plan to change name to Oncothyreon
8. Ardea Biosciences Announces Changes to Research Management
9. Jazz Pharmaceuticals, Inc. Announces Changes to its Board of Directors
10. Updated Drug Development Scrip Report Responds to the Pharma Industrys Major Changes
11. ProMed Alliance International Inc. Corporate Name and Trading Symbol Expected to Change Effective Tomorrow
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... ... a United States multicenter, prospective clinical study that demonstrates the accuracy of ... capable of identifying clinically significant acute bacterial and viral respiratory tract infections ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... partners with the pharmaceutical and biotechnology industries to improve patient outcomes and quality ... Several trends in analytical testing are being attributed to new regulatory requirements for ...
(Date:10/11/2017)... ... October 11, 2017 , ... At its national board ... Suneel I. Sheikh, the co-founder, CEO and chief research scientist of Minnesota-based Advanced ... for membership in ARCS Alumni Hall of Fame . ASTER Labs is ...
(Date:10/11/2017)... ... ... eye wash is a basic first aid supply for any work environment, but most personal ... rinse first if a dangerous substance enters both eyes? It’s one less decision, and likely ... dual eye piece. , “Whether its dirt and debris, or an acid or alkali, getting ...
Breaking Biology Technology:
(Date:4/6/2017)... Forecasts by Product Type (EAC), ... End-Use (Transportation & Logistics, Government & Public Sector, Utilities ... Generation Facility, Nuclear Power), Industrial, Retail, Business Organisation (BFSI), ... you looking for a definitive report on the $27.9bn ... ...
(Date:4/4/2017)... YORK , April 4, 2017   EyeLock ... today announced that the United States Patent and Trademark ... patent broadly covers the linking of an iris image ... same transaction) and represents the company,s 45 th ... latest patent is very timely given the multi-modal biometric ...
(Date:3/30/2017)... , March 30, 2017 Trends, opportunities ... (physiological and behavioral), by technology (fingerprint, AFIS, iris recognition, ... recognition, and others), by end use industry (government and ... immigration, financial and banking, and others), and by region ... , Asia Pacific , and ...
Breaking Biology News(10 mins):